Cell Therapeutics

Cell Therapeutics announces positive results from OPAL study of tosedostat

Cell Therapeutics announces positive results from OPAL study of tosedostat

Yahoo/Fly on the Wall

German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation within Early Benefit Assessment Process of Pixuvri (pixantrone)

German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation within Early Benefit Assessment Process of Pixuvri (pixantrone)

Yahoo/PR Newswire

The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013

The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013

Motley Fool

CEO Gaffe of the Week: Cell Therapeutics

CEO Gaffe of the Week: Cell Therapeutics

Motley Fool

Cell Therapeutics

Cell Therapeutics: Sell Now, Ask Questions Later

Cell Therapeutics: Sell Now, Ask Questions Later

Seeking Alpha

Cell Therapeutics

Cell Therapeutics: European Revenue Opportunity Could Represent A Turning Point

Cell Therapeutics: European Revenue Opportunity Could Represent A Turning Point

Seeking Alpha

Cell Therapeutics soars 24% on EU drug launch

Cell Therapeutics soars 24% on EU drug launch

Marketwatch

5 Pharmaceutical Companies To Present At The Rodman And Renshaw Conference On September 11

5 Pharmaceutical Companies To Present At The Rodman And Renshaw Conference On September 11

Seeking Alpha